Stem Cell Evidence Alert: Top Articles (October 2018)

Each month, the Stem Cell Evidence clinical team selects and reviews the most important new articles in haematopoietic stem cell transplantation. All content for this alert is sourced from Stem Cell Evidence.

Top Article of the Month - September 2018

Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute leukemia patients conditioned with thiotepa, busulfan, and fludarabine
Giannotti, F., Labopin, M.; et al. Journal of hematology & oncology 2018: Free Full Text

Selected new publications

SupplAzithromycin for Prevention of Graft-Versus-Host Disease: A Randomized Placebo-Controlled Trial
Barkhordar, M., Mohammadi, M., et all. International journal of hematology-oncology and stem cell research.​ 2018. Free Full Text

Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation
Chen, K., Cheng., et al.  Blood advances 2018. Free Full Text

Comparative analysis of calcineurin-inhibitor-based methotrexate and mycophenolate mofetil-containing regimens for prevention of Graft-versus-Host Disease after reduced intensity conditioning allogeneic transplantation
Chhabra, S., Liu, Y. et all. Biology of blood and marrow transplantation. 2018

Oral versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplantation Recipients
Foolad, F., Aitken, S. L., et al. Clinical infectious diseases 2018

Ruxolitinib Therapy Followed by Reduced Intensity Conditioning for Hematopoietic Cell Transplantation for Myelofibrosis - Myeloproliferative Disorders Research Consortium 114 study
Gupta, V., Kosiorek, H. E., et all. Biology of blood and marrow transplantation 2018

Significant Risk of Graft-versus-Host Disease with Exposure to Checkpoint Inhibitors Before and After Allogeneic transplantation
Ijaz, A., Khan, A. Y., et al. Biology of blood and marrow transplantation 2018

HLA mismatched donors in patients with myelodysplastic syndrome: an EBMT registry analysis
Robin, M., Porcher, R., et all. Biology of blood and marrow transplantation 2018

Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia
Speziali, C., Daly, A., et al. Leukemia & lymphoma 2018

High-Dose Chemotherapy and Blood Autologous Stem-Cell Rescue Compared With Standard Chemotherapy in Localized High-Risk Ewing Sarcoma: Results of Euro-E.W.I.N.G.99 and Ewing-2008
Whelan, J., Le Deley, M. C., et al. Journal of clinical oncology ​2018

Stem Cell Evidence - free online resource!

Stem Cell Evidence provides access to a free comprehensive collection of high-quality research relevant to haematopoietic stem cell transplantation. 

Stem Cell Evidence is produced by the NHS Blood and Transplant Systematic Review Initiative and funded by the four UK Blood Services and Oxford Biomedical Research Centre.

Stem Cell Evidence Alert - Clinical Team

Dr James Griffin
Stem Cell Evidence Clinical Champion & Clinical Director Therapeutics for NHS Blood & Transplant, responsible for a network of apheresis units and stem cell laboratories. His clinical role at University Hospitals Bristol is as a Stem Cell Transplant physician and haematologist.

Catherine Kimber
Assistant Information Specialist, NHS Blood and Transplant Systematic Review Initiative 

Please contact us if you have any suggestions or questions.